These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31727144)

  • 1. Idiopathic facial lipoatrophy in a healthy middle-aged woman: a case report.
    Purcell C; Taylor SM
    J Otolaryngol Head Neck Surg; 2019 Nov; 48(1):63. PubMed ID: 31727144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic hemi-facial lipoatrophy treated with autologous fat transfer.
    Liu SW; Cohen GF
    J Cosmet Dermatol; 2010 Sep; 9(3):226-9. PubMed ID: 20883296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe symmetrical facial lipoatrophy in a patient with discoid lupus erythematosus.
    Yesilada AK; Sevim KZ; Sirvan SS; Irmak F; Tatlidede HS
    J Craniofac Surg; 2012 Sep; 23(5):e461-3. PubMed ID: 22976708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical treatment of facial lipoatrophy].
    Caye N; Le Fourn B; Pannier M
    Ann Chir Plast Esthet; 2003 Feb; 48(1):2-12. PubMed ID: 12657329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
    Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
    HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy--report of five patients.
    Zanelato TP; Marquesini G; Colpas PT; Magalhães RF; Moraes AM
    An Bras Dermatol; 2013; 88(6 Suppl 1):120-3. PubMed ID: 24346897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial lipoatrophy and the place of ultrasound.
    Ascher B; Katz P
    Dermatol Surg; 2006 May; 32(5):698-708. PubMed ID: 16706766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
    Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
    Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique.
    Burnouf M; Buffet M; Schwarzinger M; Roman P; Bui P; Prévot M; Deleuze J; Morini JP; Franck N; Gorin I; Dupin N
    Arch Dermatol; 2005 Oct; 141(10):1220-4. PubMed ID: 16230558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of facial lipoatrophy via autologous fat transfer.
    Cohen G; Treherne A
    J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipotransfer provides effective soft tissue replacement for acquired partial lipodystrophy.
    Jeon FHK; Griffin M; Frosdick C; Butler PEM
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32404319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of facial lipoatrophy by lipofilling in HIV infected patients: retrospective study on 317 patients on 9 years].
    Uzzan C; Boccara D; Lacheré A; Mimoun M; Chaouat M
    Ann Chir Plast Esthet; 2012 Jun; 57(3):210-6. PubMed ID: 22218365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.
    Negredo E; Higueras C; Adell X; Martinez JC; Martinez E; Puig J; Fumaz CR; Muñoz-Moreno JA; Perez-Alvarez N; Videla S; Estany C; Cinquegrana D; Gonzalez-Mestre V; Clotet B
    AIDS Patient Care STDS; 2006 Dec; 20(12):829-37. PubMed ID: 17192148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full scope of effect of facial lipoatrophy: a framework of disease understanding.
    Ascher B; Coleman S; Alster T; Bauer U; Burgess C; Butterwick K; Donofrio L; Engelhard P; Goldman MP; Katz P; Vleggaar D
    Dermatol Surg; 2006 Aug; 32(8):1058-69. PubMed ID: 16918569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review.
    Kates LC; Fitzgerald R
    Aesthet Surg J; 2008; 28(4):397-403. PubMed ID: 19083552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management options for facial lipoatrophy.
    Cofrancesco J; Brown T; Martins CR
    AIDS Read; 2004 Dec; 14(12):639-40, 645-50. PubMed ID: 15619779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial fat volume in HIV-infected patients with lipoatrophy.
    Yang Y; Sitoh YY; Oo Tha N; Paton NI
    Antivir Ther; 2005; 10(4):575-81. PubMed ID: 16038484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal lipoatrophy of face: a rare esthetic complaint.
    Anbarasi K; Sathasivasubramanian S; Krithika CL; Venkatasai PM
    J Clin Imaging Sci; 2012; 2():14. PubMed ID: 22530185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the experience of reconstructive treatments from the perspective of people who suffer from facial lipoatrophy: a qualitative study.
    Gagnon M
    Int J Nurs Stud; 2012 May; 49(5):539-48. PubMed ID: 22130507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.